RenaissanceRe Holdings Ltd (RNR) stock
RNRNYSEFire, Marine & Casualty InsuranceFiscal year ends December 31Also trades as RNR.PF, RNR.PG
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 9/304% above fair value
$353.62−1.04 (-0.29%)
Close on Nov 13, 2026Market cap $14.29BP/E 10.0Yield –
RenaissanceRe EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
RenaissanceRe's EPS for the twelve months ending Sep 30, 2026 was $35.34, down 1.7% year over year. For fiscal 2025 it was $56.03, up 59.1% from the year before. Over ten years it grew 19.7% a year on average. The highest annual figure on record is $56.03 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.03 | +59.1% |
| FY2024 | Dec 31, 2024 | $35.21 | -32.6% |
| FY2023 | Dec 31, 2023 | $52.27 | – |
| FY2022 | Dec 31, 2022 | -$25.50 | – |
| FY2021 | Dec 31, 2021 | -$1.57 | -110.3% |
| FY2020 | Dec 31, 2020 | $15.31 | -6.0% |
| FY2019 | Dec 31, 2019 | $16.29 | +231.8% |
| FY2018 | Dec 31, 2018 | $4.91 | – |
| FY2017 | Dec 31, 2017 | -$6.15 | -153.8% |
| FY2016 | Dec 31, 2016 | $11.43 | +23.2% |
| FY2015 | Dec 31, 2015 | $9.28 | -26.3% |
| FY2014 | Dec 31, 2014 | $12.60 | -15.3% |
| FY2013 | Dec 31, 2013 | $14.87 | +32.4% |
| FY2012 | Dec 31, 2012 | $11.23 | – |
| FY2011 | Dec 31, 2011 | -$1.84 | -114.9% |
| FY2010 | Dec 31, 2010 | $12.31 | -8.1% |
| FY2009 | Dec 31, 2009 | $13.40 | – |
| FY2008 | Dec 31, 2008 | -$0.21 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$4.01 | -120.7% |
| Q2 FY2026 | Jun 30, 2026 | $15.75 | -8.4% |
| Q1 FY2026 | Mar 31, 2026 | $6.57 | +100.9% |
| Q4 FY2025 | Dec 31, 2025 | $17.03 | – |
| Q3 FY2025 | Sep 30, 2025 | $19.40 | -14.2% |
| Q2 FY2025 | Jun 30, 2025 | $17.20 | +82.8% |
| Q1 FY2025 | Mar 31, 2025 | $3.27 | -52.9% |
| Q4 FY2024 | Dec 31, 2024 | -$3.92 | -112.7% |
| Q3 FY2024 | Sep 30, 2024 | $22.62 | +495.3% |
| Q2 FY2024 | Jun 30, 2024 | $9.41 | +130.1% |
| Q1 FY2024 | Mar 31, 2024 | $6.94 | -46.2% |
| Q4 FY2023 | Dec 31, 2023 | $30.87 | +194.8% |
| Q3 FY2023 | Sep 30, 2023 | $3.80 | – |
| Q2 FY2023 | Jun 30, 2023 | $4.09 | – |
| Q1 FY2023 | Mar 31, 2023 | $12.91 | – |
| Q4 FY2022 | Dec 31, 2022 | $10.47 | +121.8% |
| Q3 FY2022 | Sep 30, 2022 | -$19.27 | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.53 | -180.5% |
| Q1 FY2022 | Mar 31, 2022 | -$9.10 | – |
| Q4 FY2021 | Dec 31, 2021 | $4.72 | +26.2% |
| Q3 FY2021 | Sep 30, 2021 | -$9.75 | -1137.2% |
| Q2 FY2021 | Jun 30, 2021 | $9.35 | -26.0% |
| Q1 FY2021 | Mar 31, 2021 | -$5.87 | – |
| Q4 FY2020 | Dec 31, 2020 | $3.74 | +385.7% |
| Q3 FY2020 | Sep 30, 2020 | $0.94 | +13.3% |
| Q2 FY2020 | Jun 30, 2020 | $12.63 | +51.3% |
| Q1 FY2020 | Mar 31, 2020 | -$1.89 | -129.4% |
| Q4 FY2019 | Dec 31, 2019 | $0.77 | – |
| Q3 FY2019 | Sep 30, 2019 | $0.83 | +1.2% |
| Q2 FY2019 | Jun 30, 2019 | $8.35 | +74.7% |
| Q1 FY2019 | Mar 31, 2019 | $6.43 | +352.8% |
| Q4 FY2018 | Dec 31, 2018 | -$2.10 | – |
| Q3 FY2018 | Sep 30, 2018 | $0.82 | – |
| Q2 FY2018 | Jun 30, 2018 | $4.78 | +12.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.42 | -36.9% |
| Q4 FY2017 | Dec 31, 2017 | -$0.09 | -105.3% |
| Q3 FY2017 | Sep 30, 2017 | -$12.75 | – |
| Q2 FY2017 | Jun 30, 2017 | $4.24 | – |
| Q1 FY2017 | Mar 31, 2017 | $2.25 | – |
| Q4 FY2016 | Dec 31, 2016 | $1.69 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?